ThinkFraction announced that Meta shipped Muse Spark 1.3 that same day as Anthropic released Claude Fable 5.1 and Claude Mythos 5.1.

Most companies treat AI like a traditional technology project. They ask "what can AI do for the business?" — then roll out tools org-wide and hope people use them. Six months later, nothing has moved. Meanwhile the investment is real — budget spent, team time consumed, board patience burning. And while you're waiting for adoption that never comes, competitors are pulling away and the AI frontier keeps moving. The gap compounds. The right question is: where in your business is there a process or workflow worth 10x'ing? Find that. Apply AI precisely. Measure what changes. That's where the leverage is. I've spent 20 years building products that deliver real business impact — across global asset managers, professional sports leagues, media, healthcare, retail, and CPG. The companies ranged from scrappy startups to firms with billions in AUM. In every one of them, the bottleneck was rarely the technology. It was finding the right problem to aim it at. That's what I do now through ThinkFraction. You tell me which part of your business to focus on. I dive in with a product lens to become intimately knowledgeable about the users, customers, workflows, processes, opportunities, pain points, and gaps. If the opportunity is real, we apply a bespoke AI solution — whether that's a workflow automation, an applied AI system, or a full agent team build — and we measure the outcome. If it works, we go again. We show and prove. One targeted fraction of your business at a time. No org-wide transformation roadmaps. No retainer traps. No chatbot rollouts nobody asked for. No big box solutions requiring months of InfoSec review that don't end up working for users in the end. One problem. Bespoke solution. Measurable results. Then we decide what's next. The trigger is different for everyone. Unclear strategy, inefficient workflows, costly systems and overhead affecting your P&L. All three are the same problem. That's where the conversation starts.